When a blood clot travels to the lungs and creates a blockage, every moment counts. The goal of treatment is to restore normal blood flow, prevent new clots from forming, and protect your heart and lungs from lasting damage. From medications that thin the blood to advanced procedures that remove dangerous clots, the approach depends on the severity of the blockage and your overall health. Medical teams also continuously explore new ways to improve outcomes for patients facing this life-threatening emergency.

Understanding Treatment Goals and Approaches

A pulmonary embolism, commonly called PE, occurs when a blood clot blocks an artery in the lungs, cutting off blood supply and oxygen to lung tissue. This is a medical emergency that demands immediate attention because without oxygen-rich blood, your lungs can suffer permanent damage, your heart can fail from overwork, and in severe cases, death can occur within minutes.^[1][2]

The primary aim of treating pulmonary embolism focuses on three critical objectives: breaking up existing clots or preventing them from growing larger, stopping new clots from forming elsewhere in the body, and minimizing damage to your lungs and other organs that depend on steady oxygen supply. Treatment decisions are based on several factors including how large the clot is, where exactly it sits in your lung arteries, how many clots you have, and whether you have underlying heart or lung conditions that make the situation more dangerous.^[5][6]

Doctors follow established treatment guidelines approved by medical societies and regulatory bodies. These recommendations are built on decades of research and clinical experience. At the same time, researchers continue testing new treatments in clinical trials, searching for safer and more effective ways to treat pulmonary embolism, especially in patients with complicated medical histories or particularly severe clots.^[9]

Because about 33% of people with pulmonary embolism die before receiving treatment, speed is essential. The medical team will quickly assess your condition using a combination of symptoms, physical examination, and diagnostic tests to determine the best treatment path. Your individual treatment plan will be tailored to your specific situation, taking into account your age, overall health, bleeding risk, and how your body responds to initial interventions.^[2][10]

Standard Treatment Methods

Blood Thinners: The Foundation of Treatment

Anticoagulants, commonly known as blood thinners, form the backbone of pulmonary embolism treatment for most patients. Despite their name, these medications do not actually thin your blood or dissolve existing clots. Instead, they work by making it harder for your blood to form new clots and prevent existing clots from growing larger. While you take blood thinners, your body’s natural processes gradually dissolve the existing clot over time.^[5][11]

There are several types of anticoagulants used to treat pulmonary embolism. Heparin is often given first, administered through an intravenous line (IV) or as an injection under the skin. Heparin works quickly, which makes it ideal for emergency situations. Many patients receive heparin in the hospital during the first few days of treatment. Another commonly used medication is warfarin, which comes as a pill. Warfarin takes several days to reach effective levels in your bloodstream, so it’s often started alongside heparin. Patients taking warfarin need regular blood tests to ensure the dose is correct because too much increases bleeding risk while too little fails to prevent clots.^[5]

Newer blood thinners called direct oral anticoagulants (DOACs) have become increasingly common. These medications work differently from warfarin and generally do not require routine blood monitoring, making them more convenient for many patients. Examples include medications that directly block specific clotting factors in your blood. Your doctor will choose the most appropriate blood thinner based on your kidney function, other medications you take, your ability to have regular blood tests, and your bleeding risk.^[12]

Most patients need to take blood thinners for at least three months after a pulmonary embolism. However, the exact duration varies greatly depending on what caused your clot. If your pulmonary embolism resulted from a temporary situation like recent surgery or a long airplane flight, you might stop blood thinners after three to six months. But if you have ongoing risk factors like cancer, genetic clotting disorders, or if doctors cannot identify what caused your clot, you may need blood thinners for much longer, possibly for life.^[15][17]

Important Considerations with Blood Thinners

Blood thinners significantly reduce your body’s ability to stop bleeding, which means even minor injuries can cause serious bleeding problems. Patients taking these medications need to watch for signs of internal bleeding including unusual bruising, blood in urine or stool, prolonged bleeding from cuts, severe headaches, dizziness, or weakness. You should tell all your healthcare providers, including dentists, that you take blood thinners before any procedure.^[15]

Certain foods and medications can interfere with blood thinners, particularly warfarin. Foods rich in vitamin K, such as leafy green vegetables, can affect how warfarin works. You do not need to avoid these foods, but you should try to eat roughly the same amount each day to keep your medication levels steady. Many over-the-counter medicines, including aspirin, other pain relievers, cold medications, and sleeping pills can also interact with blood thinners. Always check with your doctor or pharmacist before taking any new medication, even ones you can buy without a prescription.^[15]

Clot-Dissolving Medications

Thrombolytics, also called clot busters or fibrinolytic therapy, are powerful medications that actively dissolve blood clots. Unlike blood thinners that only prevent clot growth, thrombolytics break down the clot structure directly. These medications work much faster than blood thinners at clearing blockages, which can be lifesaving in severe cases where large clots cause dangerous drops in blood pressure or put extreme strain on the heart.^[5][13]

Doctors typically reserve thrombolytics for patients with massive pulmonary embolism who have very low blood pressure (systolic blood pressure below 90 mm Hg) or signs that their heart is failing from the strain. Thrombolytics may also be considered for carefully selected patients who do not have low blood pressure initially but show signs their condition is worsening despite anticoagulation treatment. Most patients with pulmonary embolism do not receive thrombolytics because the bleeding risk is substantial.^[9][12]

The main concern with thrombolytics is sudden, severe bleeding. Because these medications powerfully break down clots throughout your entire body, not just in your lungs, they can cause life-threatening bleeding in your brain, digestive system, or elsewhere. For this reason, thrombolytics are only used when the immediate danger from the pulmonary embolism outweighs the serious bleeding risk. Patients receive these medications through an IV, usually over a period of hours, with close monitoring for any signs of bleeding complications.^[12]

Vena Cava Filters

A vena cava filter is a small device inserted into the large vein (vena cava) that carries blood from your lower body to your heart. This filter acts like a trap, catching blood clots before they can travel to your lungs. Doctors use filters mainly in patients who cannot take blood thinners due to active bleeding or very high bleeding risk, or in rare cases where patients continue developing clots despite proper anticoagulation.^[5]

The filter is placed through a minimally invasive procedure. A doctor inserts a thin tube (catheter) through a vein in your groin or neck and guides it to the correct position in your vena cava using X-ray imaging. Once properly positioned, the filter expands to catch any clots traveling upward from your legs. It’s important to understand that vena cava filters do not prevent new blood clots from forming—they only prevent existing leg clots from reaching your lungs. Most patients with filters still need blood thinners once it becomes safe to use them.^[5]

Surgical and Advanced Procedures

Surgical embolectomy is an operation to physically remove blood clots from the pulmonary arteries. This surgery is rarely needed and is reserved for the most severe cases where a patient is in shock, other treatments have failed or cannot be used, or the patient’s condition is rapidly deteriorating. During the procedure, a surgeon opens the chest and removes the clot directly from the pulmonary artery. This is major surgery with significant risks, but it can be lifesaving when other options are not suitable.^[5]

A less invasive option is catheter-directed thrombolysis or catheter-assisted thrombus removal. In these procedures, doctors thread a thin, flexible tube through your blood vessels to reach the clot in your lung. Through this catheter, they can deliver clot-dissolving medication directly to the clot, or use special tools to break up or suction out the clot. These catheter-based approaches allow targeted treatment with potentially lower doses of clot-dissolving drugs compared to whole-body thrombolytic therapy, which may reduce bleeding complications.^[5][13]

One example of an advanced catheter-based system is the FlowTriever device, which allows doctors to safely and effectively remove large clots from pulmonary arteries without needing thrombolytic drugs. Another technology called EKOS uses ultrasound combined with medications through a catheter to dissolve blood clots. These minimally invasive procedures are performed in specialized cardiac catheterization laboratories by interventional cardiologists and typically require only small incisions, leading to shorter recovery times compared to open surgery.^[13]

Treatment Approaches Being Studied in Clinical Trials

While standard treatments work well for many patients, researchers continuously work to improve outcomes, reduce complications, and find better options for people with complex medical situations. Clinical trials test new medications, devices, and treatment strategies before they become widely available. Understanding what phase a clinical trial is in helps explain what researchers are learning.^[9]

Phase I trials primarily evaluate safety. These small studies involving usually fewer than 100 participants help researchers understand what dose is safe, how the body processes the treatment, and what side effects might occur. Phase II trials involve more patients and focus on whether the treatment actually works—does it dissolve clots faster, reduce complications, or improve survival? These studies also continue monitoring safety. Phase III trials are large studies comparing the new treatment directly against current standard treatment to determine if the new approach is better, equivalent, or perhaps works for specific patient groups.^[9]

Novel Anticoagulation Strategies

Researchers study improved versions of blood thinners that might work more effectively or cause fewer bleeding complications. Some clinical trials investigate whether adjusting blood thinner doses based on individual patient characteristics—such as genetic factors affecting how your body processes these medications—might improve safety and effectiveness. Scientists also explore whether combining different types of anticoagulants in specific ways could offer benefits over single-drug approaches.^[12]

Other studies examine optimal treatment duration. While current guidelines recommend at least three months of anticoagulation, trials are testing whether some patients might benefit from shorter treatment periods to reduce bleeding risk, while others might need extended or even indefinite anticoagulation to prevent recurrence. These studies often use blood tests measuring specific clotting factors or imaging studies looking at residual clot burden to help personalize treatment duration recommendations.^[12]

Advanced Thrombolytic and Catheter-Based Therapies

Clinical trials investigate refined approaches to clot dissolution. Some studies test lower doses of thrombolytic medications delivered over longer periods, hoping to maintain clot-dissolving benefits while reducing bleeding complications. Other trials examine whether delivering thrombolytics directly to the clot through catheters is safer than giving these medications throughout the whole body via standard IV administration.^[12]

Researchers also evaluate newer catheter devices designed to mechanically break apart or remove clots more efficiently. Some devices use ultrasound energy to fragment clots while simultaneously delivering medication. Others employ sophisticated suction systems or retrieval baskets to physically extract clot material. Clinical trials compare these mechanical approaches against standard treatments, looking at outcomes including how quickly patients recover, how much lung function is preserved, and whether there are fewer bleeding complications.^[12][13]

Preventing Post-PE Complications

Even after successful treatment, some patients develop long-term complications. Chronic thromboembolic pulmonary hypertension (CTEPH) occurs when old clot material remains in lung arteries, causing persistently high blood pressure in the lungs and potentially leading to heart failure. This serious condition affects a small percentage of pulmonary embolism survivors. Clinical trials investigate medications originally developed for other forms of pulmonary hypertension to see if they help patients with CTEPH. Some studies test whether more aggressive early treatment of acute pulmonary embolism might prevent CTEPH development.^[6]

Researchers also study rehabilitation programs. Pulmonary rehabilitation combines exercise training, education, and support to help patients recover strength and lung function after pulmonary embolism. Clinical trials evaluate whether structured rehabilitation programs improve quality of life, exercise capacity, and mental health outcomes compared to standard follow-up care. Some studies examine whether starting rehabilitation early during recovery leads to better results than waiting until after acute treatment is complete.^[18]

Biomarkers and Risk Stratification

Not all pulmonary embolisms are equally dangerous. Some patients have small clots causing minimal symptoms, while others have massive clots causing life-threatening heart strain. Clinical trials investigate blood tests and imaging findings that might better predict which patients need aggressive treatment and which can safely receive standard care. These predictive tools, called biomarkers, include substances released when heart muscle is stressed or damaged, proteins involved in blood clotting, and specific imaging patterns on CT scans or ultrasound.^[9]

For example, elevated levels of certain proteins like troponin or brain natriuretic peptide suggest the heart is under significant strain from the pulmonary embolism. Studies examine whether patients with elevated biomarkers benefit from more intensive treatment, even if their blood pressure remains stable. If validated, these biomarkers could help doctors identify high-risk patients who need close monitoring or more aggressive intervention before their condition deteriorates.^[9]

Recovery and Long-Term Management

Recovery from pulmonary embolism varies significantly among patients. Some people feel better within days, while others experience shortness of breath, fatigue, and reduced exercise capacity for weeks or months. Most people can begin light walking and simple household activities soon after treatment starts, but you may tire easily or feel winded even with minimal exertion. Your doctor will provide specific guidance about what activities are safe as you recover.^[15][17]

Physical rehabilitation plays an important role in recovery. Your doctor may prescribe specific exercises to rebuild your strength and improve breathing. These typically start gently and gradually increase in intensity as your condition improves. It’s important to follow your doctor’s recommendations carefully—pushing yourself too hard can worsen symptoms, but staying too inactive can slow recovery and increase the risk of new blood clots. Pay attention to your body’s signals and stop any activity that causes chest pain, severe shortness of breath, or abnormal swelling.^[15][18]

Preventing future blood clots becomes a priority after experiencing pulmonary embolism. Beyond taking your prescribed blood thinners, several lifestyle measures help reduce risk. Stay as active as your condition allows—regular movement keeps blood flowing and reduces the chance of clots forming in your legs. When you must sit for long periods during travel or work, take breaks every hour to stand up and walk around. While seated, you can pump your feet up and down, pulling your toes toward your knees then pointing them down, to keep leg blood moving.^[17][19]

Your doctor might recommend wearing compression stockings, which are special tight socks that help blood flow up from your legs toward your heart. These stockings are tighter around the ankle and gradually become looser moving up your leg, which helps push blood upward against gravity. You’ll need a prescription specifying the correct pressure level for your situation. Not everyone needs compression stockings, so ask your doctor whether they would benefit you.^[15][17]

Maintaining overall cardiovascular health supports recovery and reduces future risk. If you smoke, quitting is one of the most important steps you can take. Smoking damages blood vessels and increases clotting risk. Maintaining a healthy weight through balanced eating and regular physical activity also helps. Some patients need to reconsider hormone-based medications like birth control pills or hormone replacement therapy, as these can increase clotting risk. Discuss all your medications and supplements with your doctor to ensure they don’t unnecessarily increase bleeding or clotting risk.^[17][21]

Watch for signs that a new blood clot might be forming in your leg, which could lead to another pulmonary embolism. Contact your doctor right away if you notice swelling in one leg, persistent pain or tenderness in your calf or thigh, warmth in one area of your leg, or redness of the skin. These symptoms suggest a possible deep vein thrombosis developing, which needs immediate medical attention.^[17]

Regular follow-up care is essential. Your doctor will monitor your recovery, adjust medications as needed, check for complications, and help you understand how long you’ll need blood thinners. Some patients need routine blood tests to monitor their anticoagulation levels, while others taking newer blood thinners may not require regular testing. Your healthcare team might also recommend periodic imaging studies to ensure the clot is resolving and check for any lasting lung damage.^[13][17]

Emotional and Mental Health Considerations

Experiencing a pulmonary embolism can be emotionally traumatic. Facing a life-threatening medical emergency, enduring hospitalization, and adjusting to new limitations during recovery often triggers anxiety, fear, or depression. You might worry constantly about having another pulmonary embolism, feel scared every time you experience normal aches or pains, or struggle with the lifestyle changes required during recovery. These emotional responses are normal and understandable.^[15]

If you feel persistently anxious, sad, or overwhelmed, tell your doctor. Mental health support is an important part of recovery. Your healthcare provider can refer you to counseling services or support groups where you can connect with others who have experienced similar health challenges. Some patients benefit from working with therapists who specialize in helping people cope with serious medical conditions. Taking care of your mental health is just as important as taking care of your physical health during recovery.^[15]

Most Common Treatment Methods

• Anticoagulant Medications (Blood Thinners)
  • Heparin administered intravenously or by injection, used initially in hospitals for rapid effect
  • Warfarin taken as a pill, requires regular blood monitoring to maintain proper dosing
  • Direct oral anticoagulants (DOACs) that block specific clotting factors, typically not requiring routine blood tests
  • Treatment duration usually at least three months, sometimes much longer depending on underlying causes
  • Work by preventing new clot formation and stopping existing clots from growing while the body naturally dissolves them
• Thrombolytic Therapy (Clot Busters)
  • Powerful medications that actively dissolve blood clots throughout the body
  • Reserved for severe cases with dangerously low blood pressure or significant heart strain
  • Delivered through intravenous infusion with close monitoring
  • Carry substantial bleeding risk, limiting use to life-threatening situations
• Catheter-Based Procedures
  • Catheter-directed thrombolysis delivering clot-dissolving medication directly to the blockage
  • Mechanical thrombectomy using devices like FlowTriever to physically remove clots
  • EKOS therapy combining ultrasound energy with medication to break down clots
  • Performed in specialized cardiac catheterization laboratories through minimally invasive approaches
• Vena Cava Filter Placement
  • Small device inserted into the large vein carrying blood from lower body to heart
  • Catches blood clots before they reach the lungs
  • Used mainly when blood thinners cannot be given due to bleeding concerns
  • Placed through minimally invasive procedure using imaging guidance
• Surgical Embolectomy
  • Open chest surgery to directly remove blood clots from pulmonary arteries
  • Reserved for most severe cases where other treatments have failed or cannot be used
  • Major procedure with significant risks but potentially lifesaving in extreme situations
• Supportive Care and Rehabilitation
  • Oxygen therapy to maintain adequate blood oxygen levels
  • Pain management for chest discomfort during recovery
  • Pulmonary rehabilitation combining exercise training, education, and support
  • Compression stockings to promote blood flow from legs and prevent new clots